ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Celleron picks up discarded cancer drug from Roche pharmatimes
August 14, 2020Oxford, UK-based Celleron Therapeutics has signed a licensing agreement with Roche for exclusive rights to emactuzumab, a monoclonal antibody and tumour microenvironment modulator. -
Celleron licenses cancer drug emactuzumab from Roche pharmaceutical-technology
August 14, 2020UK-based Celleron Therapeutics has entered an exclusive licensing agreement with Roche for global rights to the clinical development, manufacturing and commercialisation of cancer drug, emactuzumab.
Pharma Sources Insight January 2025
